Oxybutynin Chloride recall: Failed Dissolution
Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc, Philadelphia, PA 19154 NDC: 62175-271-37
Why was Oxybutynin Chloride recalled?
Failed Dissolution Specifications
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lots: 18226783A, exp 07/2021 and 18232540A, exp 08/2021
- Product
- Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc, Philadelphia, PA 19154 NDC: 62175-271-37
- Recalling firm
- Lannett Company Inc.
- Quantity
- 14,448 bottles
- Distribution
- Nationwide, including Puerto Rico.
- Recall date
- March 20, 2019
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)